ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0882

Gender Differences in Rheumatology Authorship: A Bibliometric Analysis of High Impact Rheumatology Journals from 2019-2021

Neha Chaurasia1, Priyanka Iyer1 and Melody Esmaeili-Ghahfarokhi2, 1University of California Irvine, Orange, CA, 2University of California Irvine, Orange

Meeting: ACR Convergence 2022

Keywords: COVID-19, gender, work

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Psychology/Social Sciences Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Recent data suggests the COVID-19 pandemic disproportionately affected productivity of women in the workforce. This bibliometric analysis examines gender differences in authorship of manuscripts in select rheumatology journals prior to coronavirus 2019 (COVID-19) and during the early pandemic.

Methods: All manuscripts in the categories of article, review, or editorial that were published between March 1, 2019 to March 1, 2021 in 3 high‐impact rheumatology journals (Annals of the Rheumatic Diseases, Arthritis and Rheumatology, and Arthritis Care and Research) were identified using Web of Science. Authors’ genders were determined by matching first name with predicted gender using a validated multinational database (Genderize.io) and manual review of any names with less than 90% probability. The names that could not be clarified (n = 41) were excluded from further analysis. Data analysis identified the number of women and men who were first authors and senior authors, the types of manuscripts and whether the articles were related to COVID-19.
A total of 1,417 manuscripts were identified and 1,377 were analyzed and grouped by earliest date of publication from 3/1/2019 to 3/1/2020 (labeled as 2019) or 3/2/2020 to 3/1/2021 (labeled as 2020). Proportions were compared using χ2 analysis.

Results: In 2019, women were first authors of 311 manuscripts and senior authors of 198. In 2020, women were first authors of 349 manuscripts and senior authors of 252. Females represented 48% (660 of 1377) of all first authors and 34.6% (450 of 1301) of senior authors across both years. Females were 48.7% and 47.2% of first authors from 2019 and 2020, respectively. In evaluating senior authors, 32.6% and 36.3% were female in 2019 and 2020, respectively (Table 1). Women’s authorship significantly increased from 2019 to 2020 as first authors of articles and reviews (p = 0.03 and 0.05 respectively). Of the manuscripts related to COVID-19 (n=43), women were first authors of 46.5% and senior authors of 28%, with no significant difference between genders (p = 0.11).

Conclusion: This analysis explored female authorship in high impact rheumatology journals in the time before and during the COVID-19 pandemic. Females accounted for 47.8% of all first authors and demonstrated significant increase in first authorship, notably in articles and reviews, but also with an overall increasing trend. This demonstrates an improving gender equity amongst first authors. Albeit a small sample (n=42), there was no significant difference between genders in authorship related to COVID-19 (p =0.11). A very notable finding was that only about a third of senior authors were female overall, and this did not significantly change across the two years (p = 0.19), with 33% and 36% of senior authors identified as female in 2019 and 2020, respectively. Based on this snapshot in time surrounding the COVID-19 pandemic, there is undoubtedly room for improvement with senior authorship. However, it is encouraging to see that there is growth in female authorship in major rheumatology journals, rather than a decrease in authorship that some anticipated during this pandemic.

Supporting image 1

Table 1. Gender Differences Amongst First and Senior Authors by Manuscript Type Between 2019 and 2020


Disclosures: N. Chaurasia, None; P. Iyer, None; M. Esmaeili-Ghahfarokhi, None.

To cite this abstract in AMA style:

Chaurasia N, Iyer P, Esmaeili-Ghahfarokhi M. Gender Differences in Rheumatology Authorship: A Bibliometric Analysis of High Impact Rheumatology Journals from 2019-2021 [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/gender-differences-in-rheumatology-authorship-a-bibliometric-analysis-of-high-impact-rheumatology-journals-from-2019-2021/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gender-differences-in-rheumatology-authorship-a-bibliometric-analysis-of-high-impact-rheumatology-journals-from-2019-2021/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology